Tevogen Bio Inc.
(TVGN)
undefined
undefined%
At close: undefined
1.60
4.58%
Pre-market Jan 08, 2025, 05:17 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 |
| Revenue | n/a | n/a | n/a |
| Cost of Revenue | n/a | n/a | n/a |
| Gross Profit | n/a | n/a | n/a |
| Operating Income | -8.84K | -13.72M | -4.62M |
| Interest Income | n/a | n/a | n/a |
| Pretax Income | -67.33K | 4.41M | -15.60M |
| Net Income | -67.33K | 4.41M | -15.60M |
| Selling & General & Admin | 2.27M | 953.08K | 1.66M |
| Research & Development | n/a | 5.77M | 2.96M |
| Other Expenses | n/a | -7.38M | -10.38M |
| Operating Expenses | 2.27M | 953.08K | 4.62M |
| Interest Expense | 256.03K | n/a | 598.50K |
| Selling & Marketing Expenses | n/a | n/a | n/a |
| Cost & Expenses | 2.27M | 953.08K | 4.62M |
| Income Tax | n/a | -230.82K | -9.78M |
| Shares Outstanding (Basic) | 165.42M | 120.00M | 120.00M |
| Shares Outstanding (Diluted) | 165.42M | 120.00M | 120.00M |
| EPS (Basic) | -0.00 | 0.04 | -0.13 |
| EPS (Diluted) | -0.00 | 0.04 | -0.13 |
| EBITDA | 188.71K | -953.08K | -28.75K |
| Depreciation & Amortization | 197.55K | 230.82K | 9.38K |